GlioCure
PrivateLast Round
Crowdfunding
Feb 15, 2024
Total Funding Raised
$1.64M
Company Overview
GlioCure operates in Healthcare & Life Sciences and is based in Angers. Its latest recorded funding round was a Seed round in December 2023.
GlioCure is a biotechnology company that develops neuro-oncology drugs and therapeutic peptides for the treatment of glioblastoma and other brain tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlioCure Comparables
Compare GlioCure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PEP-Therapy | 80% | |
| PeptiMimesis | 79% | |
| MimiVax Inc. | 78% |
For institutional investors. Book with your work email.
GlioCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Feb 15, 2024 | ||||
| Seed | Dec 18, 2023 | ||||
| Grant | Feb 21, 2023 | ||||
| Debt | Apr 13, 2021 | ||||
| Seed | May 12, 2020 | ||||
Pre Seed | Oct 1, 2017 |
For institutional investors. Book with your work email.
GlioCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Happy Capital | Seed, Crowdfunding |
| ICO INNOV | Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 106% MoM, reaching 2K.
- Nov 8, 2025
Monthly visitors grew 107% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- declares_bankruptcySep 22, 2026
GlioCure SAS enters judicial liquidation in France nearly ten years after its creation, without judicial reorganization, as it lacks funding to continue developing neuro-oncology therapies.
For institutional investors. Book with your work email.
GlioCure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlioCure's valuation, stock price, and market status.
Is GlioCure a public or private company?
GlioCure is a private company.
What is the current stock price of GlioCure?
GlioCure is a private company, so its shares have no public market price. Caplight tracks GlioCure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlioCure worth (valuation)?
Valuation information for GlioCure is not publicly available.
Can I buy GlioCure stock?
GlioCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlioCure's last funding round?
GlioCure's most recent funding round was Crowdfunding on February 15, 2024.
Who are the main investors in GlioCure?
Key investors in GlioCure include Happy Capital, ICO INNOV, Bpifrance.
Will GlioCure IPO soon?
No public IPO plans have been announced for GlioCure.
How can I track GlioCure secondary market activity?
Caplight tracks bids, offers, and trades in GlioCure's shares on secondary markets.